The antibody in SLE with decreased risk of nephritis?
**Core Concept**
The question is testing the understanding of **Systemic Lupus Erythematosus (SLE)**, an autoimmune disease characterized by the production of various autoantibodies. In SLE, certain antibodies are associated with specific clinical manifestations, including renal involvement.
**Why the Correct Answer is Right**
Although the correct answer choice is missing, typically, **anti-Ro (SS-A) antibodies** are associated with a decreased risk of nephritis in SLE patients. These antibodies are more commonly linked to photosensitivity, subacute cutaneous lupus, and neonatal lupus.
**Why Each Wrong Option is Incorrect**
**Option A:** Without the specific answer choices, it's challenging to provide detailed incorrect option analysis. However, generally, options that include antibodies like **anti-dsDNA** or **anti-Sm** would be incorrect because they are associated with an increased risk of nephritis.
**Option B:** Similarly, this would depend on the specific antibody listed, but **anti-La (SS-B)** might not necessarily be correct in this context either.
**Option D:** Again, without the specific choice, it's hard to say, but any option suggesting an antibody associated with increased renal risk would be incorrect.
**Clinical Pearl / High-Yield Fact**
A key point to remember is that **anti-dsDNA antibodies** are strongly associated with lupus nephritis, making them a critical marker for monitoring disease activity and renal involvement in SLE patients.
**Correct Answer:** Correct Answer: D. Anti-Ro (SS-A) antibodies.